Brief: Pfizer To Complete The Acquisition Of Seagen After Receiving Regulatory Approvals

Seagen

12/12/2023 11:57

Dec 12 (Reuters) - Pfizer Inc  PFE.N :
    * PFIZER RECEIVES ALL REQUIRED REGULATORY APPROVALS TO
COMPLETE
THE ACQUISITION OF SEAGEN
    * PFIZER RECEIVES ALL REQUIRED REGULATORY APPROVALS TO
COMPLETE
THE ACQUISITION OF SEAGEN
    * PFIZER INC - EXPECTS TO CLOSE SEAGEN ACQUISITION ON
DECEMBER 14,
2023
    * PFIZER INC - ANNOUNCES CHANGES IN COMMERCIAL ORGANIZATION
TO
INCORPORATE SEAGEN AND IMPROVE FOCUS, SPEED AND EXECUTION
    * PFIZER INC - WILL CREATE AN END-TO-END BUSINESS
ORGANIZATION
CALLED PFIZER ONCOLOGY DIVISION
    * PFIZER INC - WILL SPLIT ITS NON-ONCOLOGY COMMERCIAL
ORGANIZATION
INTO TWO MORE FOCUSED BUSINESS DIVISIONS
    * PFIZER INC - NEW ORGANIZATION STRUCTURE WILL GO INTO
EFFECT
JANUARY 1, 2024
    * PFIZER - TO ADDRESS U.S. FTC CONCERNS, TO IRREVOCABLY
DONATE
RIGHTS OF ROYALTIES FROM SALES OF BAVENCIO (AVELUMAB) IN U.S. TO
AACR

Source text for Eikon:  ID:nBw2b1t1ya 
Further company coverage:  PFE.N 

 ((Reuters.Briefs@thomsonreuters.com;))